Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, et al. N Engl J Med 2024 Sep 15. doi: 10.1056/NEJMoa2407417.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, et al. Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. N Engl J Med 2024 Sep 15. doi: 10.1056/NEJMoa2407417.
PMID: 39282897